Literature DB >> 29158308

Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.

Soliman Oushy1,2, Justin E Hellwinkel1,2, Mary Wang2, Ger J Nguyen2, Dicle Gunaydin2, Tessa A Harland1,2, Thomas J Anchordoquy3, Michael W Graner4.   

Abstract

Glioblastoma multiforme (GBM) is a devastating tumour with abysmal prognoses. We desperately need novel approaches to understand GBM biology and therapeutic vulnerabilities. Extracellular vesicles (EVs) are membrane-enclosed nanospheres released locally and systemically by all cells, including tumours, with tremendous potential for intercellular communication. Tumour EVs manipulate their local environments as well as distal targets; EVs may be a mechanism for tumourigenesis in the recurrent GBM setting. We hypothesized that GBM EVs drive molecular changes in normal human astrocytes (NHAs), yielding phenotypically tumour-promoting, or even tumourigenic, entities. We incubated NHAs with GBM EVs and examined the astrocytes for changes in cell migration, cytokine release and tumour cell growth promotion via the conditioned media. We measured alterations in intracellular signalling and transformation capacity (astrocyte growth in soft agar). GBM EV-treated NHAs displayed increased migratory capacity, along with enhanced cytokine production which promoted tumour cell growth. GBM EV-treated NHAs developed tumour-like signalling patterns and exhibited colony formation in soft agar, reminiscent of tumour cells themselves. GBM EVs modify the local environment to benefit the tumour itself, co-opting neighbouring astrocytes to promote tumour growth, and perhaps even driving astrocytes to a tumourigenic phenotype. Such biological activities could have profound impacts in the recurrent GBM setting.This article is part of the discussion meeting issue 'Extracellular vesicles and the tumour microenvironment'.
© 2017 The Author(s).

Entities:  

Keywords:  astrocytes; exosomes; extracellular vesicles; glioblastoma multiforme; microenvironment; signalling

Mesh:

Substances:

Year:  2018        PMID: 29158308      PMCID: PMC5717433          DOI: 10.1098/rstb.2016.0477

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  86 in total

1.  A genetically tractable model of human glioma formation.

Authors:  J N Rich; C Guo; R E McLendon; D D Bigner; X F Wang; C M Counter
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 2.  Exosomes in Viral Disease.

Authors:  Monique R Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

3.  SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma.

Authors:  Anyan Liao; Ranran Shi; Yuliang Jiang; Suqing Tian; Panpan Li; Fuxi Song; Yalan Qu; Jinna Li; Haiqin Yun; Xiangshan Yang
Journal:  Mol Neurobiol       Date:  2014-11-25       Impact factor: 5.590

4.  Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes.

Authors:  Alessandra Lo Cicero; Gabriella Schiera; Patrizia Proia; Patrizia Saladino; Giovanni Savettieri; Carlo Maria Di Liegro; Italia Di Liegro
Journal:  Int J Oncol       Date:  2011-08-12       Impact factor: 5.650

5.  Glioma-derived extracellular vesicles selectively suppress immune responses.

Authors:  Justin E Hellwinkel; Jasmina S Redzic; Tessa A Harland; Dicle Gunaydin; Thomas J Anchordoquy; Michael W Graner
Journal:  Neuro Oncol       Date:  2015-09-18       Impact factor: 12.300

Review 6.  Interleukins in glioblastoma pathophysiology: implications for therapy.

Authors:  Y T Yeung; K L McDonald; T Grewal; L Munoz
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 7.  Radiation-induced gliomas.

Authors:  Gautam Prasad; Daphne A Haas-Kogan
Journal:  Expert Rev Neurother       Date:  2009-10       Impact factor: 4.618

8.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

Review 9.  Cancer associated fibroblasts in cancer pathogenesis.

Authors:  Omar E Franco; Aubie K Shaw; Douglas W Strand; Simon W Hayward
Journal:  Semin Cell Dev Biol       Date:  2009-11-05       Impact factor: 7.727

10.  Treatment options in newly diagnosed glioblastoma.

Authors:  Eudocia Q Lee; Lakshmi Nayak; Patrick Y Wen; David A Reardon
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

View more
  28 in total

Review 1.  Tumor-derived extracellular vesicles: molecular parcels that enable regulation of the immune response in cancer.

Authors:  Colin Sheehan; Crislyn D'Souza-Schorey
Journal:  J Cell Sci       Date:  2019-10-15       Impact factor: 5.285

Review 2.  Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized Influence.

Authors:  Michael W Graner
Journal:  Annu Rev Genomics Hum Genet       Date:  2019-04-12       Impact factor: 8.929

3.  Glioblastoma Extracellular Vesicle-Specific Peptides Inhibit EV-Induced Neuronal Cytotoxicity.

Authors:  Wenbo Zhou; Julia Craft; Alex Ojemann; Luke Bergen; Arin Graner; Aitana Gonzales; Qianbin He; Timothy Kopper; Marie Smith; Michael W Graner; Xiaoli Yu
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

Review 4.  Tumor-derived exosomes, microRNAs, and cancer immune suppression.

Authors:  Michael W Graner; Sathya Schnell; Michael R Olin
Journal:  Semin Immunopathol       Date:  2018-06-04       Impact factor: 9.623

5.  Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.

Authors:  Zhen Sun; Li Wang; Yueling Zhou; Lihua Dong; Weichao Ma; Liang Lv; Jie Zhang; Xiujie Wang
Journal:  Cell Mol Neurobiol       Date:  2019-12-18       Impact factor: 5.046

Review 6.  Extracellular Vesicle-Mediated Bilateral Communication between Glioblastoma and Astrocytes.

Authors:  Lisa Nieland; Liza M Morsett; Marike L D Broekman; Xandra O Breakefield; Erik R Abels
Journal:  Trends Neurosci       Date:  2020-11-21       Impact factor: 13.837

7.  EPC-Derived Exosomal miR-1246 and miR-1290 Regulate Phenotypic Changes of Fibroblasts to Endothelial Cells to Exert Protective Effects on Myocardial Infarction by Targeting ELF5 and SP1.

Authors:  Yulang Huang; Lifang Chen; Zongming Feng; Weixin Chen; Shaodi Yan; Rongfeng Yang; Jian Xiao; Jiajia Gao; Debao Zhang; Xiao Ke
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 8.  Breaking through the glioblastoma micro-environment via extracellular vesicles.

Authors:  Thomas Simon; Ellen Jackson; Georgios Giamas
Journal:  Oncogene       Date:  2020-05-04       Impact factor: 9.867

9.  Extracellular vesicles in the tumour microenvironment.

Authors:  David Raul Francisco Carter; Aled Clayton; Andrew Devitt; Stuart Hunt; Daniel W Lambert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

Review 10.  Exosome Traceability and Cell Source Dependence on Composition and Cell-Cell Cross Talk.

Authors:  Rabab N Hamzah; Karrer M Alghazali; Alexandru S Biris; Robert J Griffin
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.